Antibiotice plans production for critical medicines
Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Ceres Pharma, a Belgian pharmaceutical group, has announced the official completion of the integration process between its Romanian subsidiaries, Dacia Plant and Viva Pharma.
Novartis has over 550 employees in Romania and operates a manufacturing unit in the country.
Turnover was approximately RON 231 million in the first nine months of the year.
Opening of STADA production and supply-chain hub in Turda, Romania, strengthens European security of supply with more than 150 million packs of medicines per year.

The Romanian government has launched a comprehensive legislative package aimed at dismantling bureaucratic barriers for large-scale investments.
Romania's annual inflation rate saw a marginal decrease in February 2026, dropping to 9.31% from the 9.62% recorded in January.
Bulgaria, Croatia, Poland, and Romania could raise labour productivity by up to 10 to 15% through wider adoption of digital technologies, particularly software and AI-enabled tools, according to a report by World Bank Group.
Romania continues to record the lowest uptake of e-government services in the European Union.
World Class Romania, part of Vectr Holdings, has appointed Matei Filipidescu as CEO. He is replacing Kent Orrgren, who concluded his term as CEO after nine years.